Neuropeptide-processing enzymes: Applications for drug discovery

Neuropeptides serve many important roles in communication between cells and are an attractive target for drug discovery. Neuropeptides are produced from precursor proteins by selective cleavages at specific sites, and are then broken down by further cleavages. In general, the biosynthetic cleavages occur within the cell and the degradative cleavages occur postsecretion, although there are exceptions where intracellular processing leads to inactivation, or extracellular processing leads to activation of a particular neuropeptide. A relatively small number of peptidases are responsible for processing the majority of neuropeptides, both inside and outside of the cell. Thus, inhibition of any one enzyme will lead to a broad effect on several different neuropeptides and this makes it unlikely that such inhibitors would be useful therapeutics. However, studies with mutant animals that lack functional peptide-processing enzymes have facilitated the discovery of novel neuropeptides, many of which may be appropriate targets for therapeutics.

[1]  L. Fricker,et al.  Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. , 2005, Journal of mass spectrometry : JMS.

[2]  S. Ye,et al.  Membrane bound members of the M1 family: more than aminopeptidases. , 2004, Protein and peptide letters.

[3]  S. Snyder,et al.  Enkephalin convertase: purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[4]  L. Orci,et al.  Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice* , 2001, The Journal of Biological Chemistry.

[5]  D. Steiner,et al.  Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2. , 1990, The Journal of biological chemistry.

[6]  L. Schoofs,et al.  The use of peptidomics in endocrine research. , 2003, General and comparative endocrinology.

[7]  L. Orci,et al.  Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Mains,et al.  Quantitative peptidomics of pituitary glands from mice deficient in copper transport. , 2003, Cellular and molecular biology.

[9]  L. Fricker,et al.  Peptidomics of Cpe fat/fat mouse hypothalamus: effect of food deprivation and exercise on peptide levels. , 2005, The Journal of biological chemistry.

[10]  R. Mains,et al.  Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. , 1994, The Journal of biological chemistry.

[11]  I. Lindberg,et al.  The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1 , 2000, FEBS letters.

[12]  L. Devi,et al.  Characterization of Endothelin-converting Enzyme-2 , 2003, The Journal of Biological Chemistry.

[13]  F. Eng,et al.  Localization of Metallocarboxypeptidase D in AtT-20 Cells , 1999, The Journal of Biological Chemistry.

[14]  A. Viale,et al.  Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. , 1996, Endocrinology.

[15]  J. Halford,et al.  Orexins and appetite regulation , 2002, Neuropeptides.

[16]  E. Kalso,et al.  Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. , 1999, Molecular pharmacology.

[17]  P. Aloy,et al.  The Crystal Structure of the Inhibitor-complexed Carboxypeptidase D Domain II and the Modeling of Regulatory Carboxypeptidases* , 2001, The Journal of Biological Chemistry.

[18]  G. Greeley,et al.  Effect of Carboxypeptidase E Deficiency on Progastrin Processing and Gastrin Messenger Ribonucleic Acid Expression in Mice with the fat Mutation* , 1997 .

[19]  S. Patterson,et al.  Identification and Characterization of proSAAS, a Granin-Like Neuroendocrine Peptide Precursor that Inhibits Prohormone Processing , 2000, The Journal of Neuroscience.

[20]  Haiyang Li,et al.  Identification of peptides from brain and pituitary of Cpefat/Cpefat mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Rodriguiz,et al.  Deficits in reproduction and pro-gonadotropin-releasing hormone processing in male Cpefat mice. , 2004, Endocrinology.

[22]  F. Strand,et al.  Neuropeptides: general characteristics and neuropharmaceutical potential in treating CNS disorders. , 2003, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[23]  E. Leiter,et al.  Induced and Spontaneous Mutations at Ser202 of Carboxypeptidase E , 1996, The Journal of Biological Chemistry.

[24]  Richard D. Smith,et al.  Stable isotope-coded proteomic mass spectrometry. , 2003, Current opinion in biotechnology.

[25]  N. Seidah,et al.  The C-terminal Region of proSAAS Is a Potent Inhibitor of Prohormone Convertase 1* , 2000, The Journal of Biological Chemistry.

[26]  R. Mains,et al.  The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. , 1993, The Journal of biological chemistry.

[27]  L. Fricker,et al.  Catalysis of Slow C‐Terminal Processing Reactions by Carboxypeptidase H , 1989, Journal of neurochemistry.

[28]  D. Steiner,et al.  Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Cahill,et al.  Novel roles of neuropeptide processing enzymes: EC3.4.24.15 in the neurome , 2003, Journal of neuroscience research.

[30]  L. Fricker Peptide Biosynthesis and Processing , 1991 .

[31]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[32]  Lloyd D. Fricker,et al.  Quantitation of Neuropeptides in Cpefat/Cpefat Mice Using Differential Isotopic Tags and Mass Spectrometry , 2002 .

[33]  A. Yamanaka,et al.  Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Huttner,et al.  Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase. , 1983, The Journal of biological chemistry.

[35]  L. Fricker,et al.  Regulation of carboxypeptidase E. Effect of Ca2+ on enzyme activity and stability. , 1994, The Journal of biological chemistry.

[36]  Yun Feng,et al.  Identification and distribution of mouse carboxypeptidase A-6. , 2005, Brain research. Molecular brain research.

[37]  M. Permutt,et al.  Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity , 2001, Human mutation.

[38]  I. Clarke,et al.  Post-secretory processing of peptide signals: a novel mechanism for the regulation of peptide hormone receptors. , 1997, Biochemical Society transactions.

[39]  A. Prat,et al.  Precursor convertases in the secretory pathway, cytosol and extracellular milieu. , 2002, Essays in biochemistry.

[40]  L. Orci,et al.  Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Svenningsson,et al.  Peptidomics-based discovery of novel neuropeptides. , 2003, Journal of proteome research.

[42]  G. Martens,et al.  7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway , 1994, Cell.

[43]  M. Yanagisawa,et al.  Endothelin-converting Enzyme-2 Is a Membrane-bound, Phosphoramidon-sensitive Metalloprotease with Acidic pH Optimum (*) , 1995, The Journal of Biological Chemistry.

[44]  D. Steiner,et al.  Post-translational proteolysis in polypeptide hormone biosynthesis. , 1982, Annual review of physiology.

[45]  L. Fricker,et al.  Purification and Characterization of Carboxypeptidase D, a Novel Carboxypeptidase E-like Enzyme, from Bovine Pituitary (*) , 1995, The Journal of Biological Chemistry.

[46]  N. Seidah,et al.  Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, Furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. , 1991, Molecular endocrinology.

[47]  A. Turner Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries. , 2003, Biochemical Society transactions.

[48]  An Zhou,et al.  Proteolytic Processing in the Secretory Pathway* , 1999, The Journal of Biological Chemistry.

[49]  L. Fricker,et al.  Quantitation of neuropeptides in Cpe(fat)/Cpe(fat) mice using differential isotopic tags and mass spectrometry. , 2002, Analytical chemistry.

[50]  Wenge Wang,et al.  Cholecystokinin (CCK) Levels Are Greatly Reduced in the Brains But Not the Duodenums of Cpefat/Cpefat Mice: A Regional Difference in the Involvement of Carboxypeptidase E (Cpe) in Pro-CCK Processing. , 1997, Endocrinology.

[51]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[52]  O. H. Viveros,et al.  Novel peptides from adrenomedullary chromaffin vesicles. , 1993, Journal of anatomy.

[53]  S. Snyder,et al.  Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase. , 1983, The Journal of biological chemistry.

[54]  D. Aunis,et al.  Processing of Proenkephalin-A in Bovine Chromaffin Cells , 2000, The Journal of Biological Chemistry.

[55]  W. Richards,et al.  Obesity and diabetes in transgenic mice expressing proSAAS. , 2004, The Journal of endocrinology.

[56]  D. Steiner,et al.  Internal cleavage of the inhibitory 7B2 carboxyl-terminal peptide by PC2: a potential mechanism for its inactivation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Naggert,et al.  Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity , 1995, Nature Genetics.

[58]  Xiaorong Zhu,et al.  Neuropeptide processing profile in mice lacking prohormone convertase-1. , 2005, Biochemistry.

[59]  F. Avilés,et al.  Identification and Characterization of Three Members of the Human Metallocarboxypeptidase Gene Family* , 2002, The Journal of Biological Chemistry.

[60]  R. Mains,et al.  Peptidylglycine alpha-amidating monooxygenase: an ascorbate-requiring enzyme. , 1997, Methods in enzymology.

[61]  R. Mains,et al.  Peptidylglycine α‐amidating monooxygenase: A multifunctional protein with catalytic, processing, and routing domains , 1993, Protein science : a publication of the Protein Society.

[62]  S. Prigge,et al.  New insights into copper monooxygenases and peptide amidation: structure, mechanism and function , 2000, Cellular and Molecular Life Sciences CMLS.

[63]  E. Leiter,et al.  Carboxypeptidase E Activity Is Deficient in Mice with the fat Mutation , 1996, The Journal of Biological Chemistry.

[64]  L. Fricker,et al.  Relative quantitation of peptides in wild-type and Cpe(fat/fat) mouse pituitary using stable isotopic tags and mass spectrometry. , 2005, Journal of mass spectrometry : JMS.

[65]  R. Aebersold,et al.  Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. , 2003, Current opinion in biotechnology.

[66]  R. C. Johnson,et al.  The multifunctional peptidylglycine alpha-amidating monooxygenase gene: exon/intron organization of catalytic, processing, and routing domains. , 1992, Molecular endocrinology.

[67]  M. Chrétien,et al.  Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[68]  N. Seidah,et al.  Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin. , 1993, The Journal of biological chemistry.

[69]  L. Fricker,et al.  Intracellular trafficking of metallocarboxypeptidase D in AtT-20 cells: localization to the trans-Golgi network and recycling from the cell surface. , 1998, Journal of cell science.